Home | NAcGM3/VSSP/Montanide ISA 51 formulation in HIV, phase II.

The revisions let you track differences between multiple versions of a post.

To edit, publish or delete one of the revisions below, click on its saved date.

Published clinical_trials NAcGM3/VSSP/Montanide ISA 51 formulation in HIV, phase II. has 4 revisions.
RevisionStatus
Saved 19/04/2021 - 3:41pm by Gladys
current revision (published)
Saved 19/04/2021 - 3:41pm by Gladys
archived
Saved 09/12/2016 - 1:19pm by lazara
archived
Saved 09/04/2013 - 4:12pm by Webmaster
archived
Equipo de Trabajo del RPCEC | CENCEC - MINSAP
rpcec@cencec.sld.cu
Calle 5ta A Edificio CECMED-CENCEC 2do piso e/ 60 y 62 Miramar, Playa.CP 11300. La Habana, Cuba
Telef: (537) 216-4126 | (537) 216-4212 | (537) 216-4218.
Copyright © 2014-2022 All Rights Reserved.